As in the first quarter, however, continuing weak demand in the cosmetics segment led to a decline in sales of cosmetic packaging. A similar situation applies for laboratory glassware products, where a temporary sales decline was experienced because of invenÂtory reductions and purchasing cautiousness by customers.
Outlook for 2009
Despite the imponderable factors with regard to further world economic development Gerresheimer continues to expect growth in the field of pharmaceutical packaging and systems. In the more cyclical segments cosmetics and laboratory glassware, Gerresheimer experienced a marked decline in demand in the first half year. ForeÂcasts for the further course of the financial year are difficult. Gerresheimer AG does not however assume any short-term recovery of these markets. The sound balance sheet and long term financÂing structure as well as a good operating performance will enable Gerresheimer to continue the growth strategy in the pharma & life science segment going forward.
Gerresheimer employs around 10,000 people in 40 locations in Europe,
America and Asia. In the financial year 2008, worldwide sales totaled EUR
1.06bn. The product portfolio ranges from pharmaÂceuÂtical vials made of
glass and plastic through to complex drug-delivery systems for the pharma &
life science industry. These include sterile syringes, inhalers and other
system-based approaches for safe dosage and a
|SOURCE Gerresheimer AG|
Copyright©2009 PR Newswire.
All rights reserved